AbCellera Biologics (ABCL) is on the creator's watchlist, with potential for future growth due to its AI platform and pipeline, but current financial performance is a concern.
Source Post
A Stock a Day Until I Can Quit My Job: Day 35
Jul 25, 2025
This reel analyzes AbCellera Biologics (ABCL), a biotech company that uses AI for antibody discovery. While it had success during COVID-19 with Eli Lilly, its revenue and net income have declined post-pandemic. The company has a strong pipeline and significant cash reserves, but is currently on the creator's watchlist pending further catalysts.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.